Abstract
Long non‐coding RNA (lncRNA) plays an important role in the renal inflammatory response caused by hyperuricaemia. However, the underlying molecular mechanisms through which lncRNA is involved in endothelial injury induced by hyperuricaemia remain unclear. In this study, we investigated the regulatory role of lncRNA‐HOTAIR in high concentration of uric acid (HUA)–induced renal injury. We established hyperuricaemia mouse model and an in vitro uric acid (UA)–induced human umbilical vein endothelial cell (HUVEC) injury model. In HUA‐treated HUVECs and hyperuricaemia mice, we observed increased HOTAIR and decreased miR‐22 expression. The expression of pyroptosis‐associated protein (NLRP3, Caspase‐1, GSDMD‐N, GSDMD‐FL) was increased. The release of LDH, IL‐1β and IL‐18 in cell supernatants and the sera of model mice was also increased. The proliferation of HUVECs stimulated by HUA was significantly inhibited, and the number of TUNEL‐positive cells in hyperuricaemia mouse kidney was increased. Bioinformatics analysis and luciferase reporter and RIP assays confirmed that HOTAIR promoted NLRP3 inflammasome activation by competitively binding miR‐22. In gain‐ or loss‐of‐function experiments, we found that HOTAIR and NLRP3 overexpression or miR‐22 knock down activated the NLRP3 inflammasome and promoted pyroptosis in HUA‐treated HUVECs, while NLRP3 and HOTAIR knockdown or a miR‐22 mimic exerted the opposite effects. Furthermore, in vivo experiments validated that HOTAIR knockdown alleviated renal inflammation in hyperuricaemia mice. In conclusion, we demonstrated that in hyperuricaemia, lncRNA‐HOTAIR promotes endothelial cell pyroptosis by competitively binding miR‐22 to regulate NLRP3 expression.
Keywords: hyperuricaemia, LncRNA‐HOTAIR, miR‐22, NLRP3 inflammasome, pyroptosis
1. INTRODUCTION
Hyperuricaemia is a disease caused by purine metabolism disorders. It has become a risk factor for cardiovascular disease and chronic kidney disease, in addition to hypertension, diabetes, obesity, hyperlipidaemia, etc.1, 2, 3 Current studies have confirmed that high UA levels can cause microvascular disorders in the kidney, vascular endothelial dysfunction and the release of inflammatory cytokines,4, 5, 6 subsequently causing kidney damage. Renal biopsies from patients with hyperuricaemia nephropathy showed interstitial infiltration of inflammatory cells and elevated serum levels of inflammatory markers, indicating that hyperuricaemia can induce an inflammatory response and cause kidney injury.7, 8
Inflammatory damage in the kidney is inseparable from the activation of inflammasomes. In particular, the nucleotide‐binding domain and leucine‐rich repeat (NLR) protein 3 (NLRP3) inflammasome has been shown to cause acute and chronic kidney diseases by regulating canonical and non‐canonical mechanisms of inflammation.9, 10, 11 Therefore, the involvement of NLRP3 in kidney damage caused by high serum UA stimulation cannot be ignored in clinical practice. The NLRP3 inflammasome is composed of NLRP3, apoptosis‐associated speck‐like protein containing a CARD (ASC) and active caspase‐1, which regulates interleukin‐1β (IL‐1β) maturation.12, 13 Its activation promotes caspase‐1‐mediated cytokine maturation and simultaneously enhances the release of the N‐terminal domain of gasdermin D from the self‐inhibiting C‐terminal domain and subsequent transfer to the plasma membrane, forming large nanopores in the plasma membrane, thereby causing pyroptosis.14, 15, 16, 17 This process is accompanied by the release of a large number of pro‐inflammatory cytokines, further aggravating tissue inflammatory injury. Studies have shown that pyroptosis is associated with the occurrence and development of kidney diseases.18, 19, 20, 21 The major kidney damage caused by hyperuricaemia is endothelial cell dysfunction. However, the molecular mechanism by which HUA triggers the activation of inflammasomes and thereby promotes pyroptosis has not been elucidated.
Long non‐coding RNA (lncRNA) is a class of non‐coding RNA molecules over 200 nt in length. lncRNA plays important roles in cell differentiation, proliferation, apoptosis and pyroptosis.22, 23, 24 Its mechanism relies on binding with microRNAs (miRNAs) to prevent the latter from binding to target genes, thereby regulating gene expression.25, 26 Similarly, lncRNAs play important roles in the occurrence and development of kidney diseases. For example, Gm4419 increases the inflammation‐mediated inflammatory response in diabetic nephropathy through the nuclear factor‐kappa B (NF‐κB)/NLRP3 pathway.27 Metastasis‐associated lung adenocarcinoma transcript 1 (MALAT1) regulates high glucose–induced inflammatory responses in endothelial cells.28 Our previous study also confirmed that HOX transcript antisense RNA (HOTAIR) promotes the proliferation and migration of clear cell renal cell carcinoma (ccRCC) by increasing hypoxia‐inducible factor (HIF)‐1α expression via competing with miR‐217.29 lncRNAs can also promote the angiogenesis function of endothelial cells.30 These results suggest that HOTAIR might be involved in vascular endothelial cell injury induced by HUA. In acute renal injury caused by sepsis, HOTAIR promotes the apoptosis of HK‐2 cells through the miR‐22/HMGB1 pathway, thereby causing kidney injury.31 However, whether the interaction between HOTAIR and miR‐22 participates in vascular endothelial injury caused by HUA levels has not been reported.
Therefore, in this study, by culturing vascular endothelial cells and constructing a hyperuricaemia animal model, we attempted to confirm the molecular mechanism underlying kidney injury; that is, in an HUA environment, HOTAIR induces the activation of the NLRP3 inflammasome and pyroptosis by binding to miR‐22, ultimately promoting endothelial cell injury and causing kidney injury.
2. MATERIALS AND METHODS
2.1. Patients and controls
Seventeen hyperuricaemia patients at the Chinese PLA General Hospital were screened by the following criteria. The inclusion criteria for 17 hyperuricaemia patients (male 12 and female 5) were as follows: subjects are between the age of 21 and 85, with an average age of 43.5 ± 3.7 years; subjects meet the diagnostic criteria of hyperuricaemia (serum UA concentration >440 μmol/L for males and >367 μmol/L for females); first onset; informed consent. The exclusion criteria were as follows: patients with stage 3 hypertension, diabetic nephropathy and anti‐UA therapy in the previous 3 months. Among those included, 12 were male, and five were female, with an average age of 43.5 years. Additionally, we selected 17 age‐matched healthy volunteers as controls. Fasting blood samples were collected from all subjects and centrifuged at 3000 g for 10 min at 4°C. Serum samples were then collected for detecting the expression levels of HOTAIR, miR‐22, IL‐1β and IL‐18 using qPCR analysis and ELISA. This study was approved by the Ethics Committee of PLA General Hospital, and informed consent was obtained from all participants.
2.2. Cell culture
Human umbilical vein endothelial cells (HUVECs) (American Type Culture Collection, No. CRL‐1730) were cultured in endothelial culture medium (ECM) (ScienCell Research Laboratories, cat. no. 1001) containing 5% FBS, 1% endothelial cell growth supplement and 1% penicillin/streptomycin solution in a 37°C, 5% CO2 incubator. When cell confluence reached 50%, 600 μmol/L UA (Sigma‐Aldrich, cat. no. U2625) was added and then incubated for 24 h.
2.3. Lentivirus construction and cell transfection
To overexpress lncRNA‐HOTAIR or NLRP3, the full‐length cDNA fragment of human lncRNA‐HOTAIR or NLRP3 was cloned into the lentiviral vector pReceiver‐Lv185 (FulenGen), and 293T cells were used to produce pReceiver‐Lv185‐HOTAIR and pRevceiver‐NLRP3. In addition, lentivirus vectors psiH1‐HOTAIR and psiH1‐NLRP3 were used to knock down the above 2 genes. A miR‐22 mimic and inhibitor (AMO‐22) were designed and manufactured by Sangon Biotech. HUVECs were infected with the lentiviral vectors when they reached 70%–80% confluence.
2.4. Dual‐luciferase reporter assay
Using GenBank as a reference, the fragment of the NLRP3 (NM004895) 3′‐untranslated region (UTR) containing the miR‐22 targeting sequence (5′‐AAGCGU‐3′) was cloned, via PCR, into the psiCHECKTM‐2 dual‐luciferase reporter plasmid (Promega, cat. no. E1910) to produce psiCHECK‐WT‐NLRP3 and the mutant vector psiCHECK‐MT‐NLRP3. Then, the two plasmids were co‐transfected into HUVECs with either miR‐22 mimic, inhibitor or miR‐22 control. For the reporter assays, HUVECs were harvested and lysed and then the assays were conducted according to manufacturer's instructions (Promega, cat. no. E1910). Firefly and Renilla luciferase activities were measured using a dual‐luciferase reporter assay system. Firefly luciferase activity (F value) and Renilla luciferase activity (R value) were detected using a fluorescence/chemiluminescence instrument. The ratio of Renilla luciferase activity to firefly luciferase activity represented the relative expression level of reporter genes. Similarly, the region containing the target sequence in human lncRNA‐HOTAIR was cloned into the vector psiCHECKTM‐2, and similar experiments were carried out.
2.5. RNA‐binding protein immunoprecipitation (RIP) assay
RIP assays were performed using a Magna RIP RNA‐Binding Protein Immunoprecipitation Kit (Sigma‐Aldrich, cat. no. 17‐700). HUVECs were lysed in RIP lysis buffer, and subsequently, 100 μl of cell lysate was incubated with RIP buffer containing magnetic beads conjugated with human anti‐Ago2 antibody (1:50 dilution, Millipore) and corresponding negative normal control IgG (Millipore). The samples were incubated with proteinase K buffer, and target RNA was extracted for further study. qPCR assays were conducted to determine HOTAIR and miR‐22 levels in the precipitates.
2.6. RNA pulldown assay
RNA pulldown assay was carried out by using a Pierce™ Magnetic RNA‐Protein Pull‐Down Kit (Thermo Fisher, cat. no. 20164). Briefly, RNAs were biotin‐labelled and in vitro transcribed with Biotin RNA Labeling Mix and T7/SP6 RNA polymerase. Cells were lysed and incubated with biotinylated RNAs. After treated with RNase‐free DNase I (Roche, cat. no. 69182) and then purified with the RNeasy Mini Kit (Qiagen, cat. no. 74104), the bound RNAs were extracted for further evaluation by qRT‐PCR analysis.
2.7. Animals and treatment
Eight‐ to twelve‐week‐old C57/B6 male mice were provided by the Experimental Animal Center of the Academy of Military Medical Sciences (a total of 24 mice: six mice in HUA model group, six mice in HUA + Vector group and six mice in HUA + shHOTAIR group, six for control group); the animal were allowed to adapt for 1 week before the experiments. Hyperuricaemia was induced by gavage of potassium oxonate (PO; Sigma‐Aldrich, cat. no. U156124) (250 mg/kg·day) and UA (Sigma‐Aldrich, cat. no. U2625) solution (250 mg/kg·day) once a day for 10 consecutive days. A UA assay kit (abcam, cat. no. Ab65344) was used to detect serum UA levels in mice and determine whether modelling was successful.
2.8. CCK‐8 assay
HUVECs in 96‐well plates (1000–2000 cells per well) were treated with 600 µmol/L UA solution for 0 day, 1 day, 2 days, 3 days, 4 days, 5 days, 6 days or 7 days, and then, the culture medium was removed. The cells were washed twice with phosphate‐buffered saline (PBS, Beyotime, cat. no. C0221A), and then, 10 µl of CCK‐8 solution (Dojindo, cat. no. CK04) was added to each well. The cells were incubated at 37°C for 2 h, and then, the absorbance (450 nm) for each well was determined using an ELISA reader (Bio‐Rad, iMARK).
2.9. LDH release assay
To test cell cytotoxicity, we used a lactate dehydrogenase assay kit (abcam, cat. no. ab102526) to detect LDH activity in serum and cell culture supernatant. Samples were placed into a 96‐well plate, and 50 µl of reaction mixture (LDH assay buffer, 48 µl; LDH substrate mix, 2 µl) was added. After incubating 45 min at 37°C, the absorbance (450 nm) for each well was determined using an ELISA reader (Bio‐Rad, iMARK).
2.10. RNA extraction and qPCR
Total RNA was extracted from patient serum, mouse kidney tissue and HUVECs using TRIzol reagent (Invitrogen, cat. no. 15596026) following the manufacturer's protocol. One microgram of total RNA was reverse transcribed into cDNA using a First Strand cDNA Synthesis Kit (TOYOBO, cat. no. FSK‐101) according to the manufacturer's instructions. The qPCR system was prepared with a SYBR Select Master Mix kit (Thermo Fisher, cat. no. 4472903), and then, the relative expression levels of HOTAIR and miR‐22 were determined using a 7500 FAST real‐time PCR system (Applied Biosystems) according to standard procedures. 18s rRNA was used for normalization. The primers are provided in Table 1.
TABLE 1.
Forward | Reverse | |
---|---|---|
HOTAIR (murine) | 5′‐CCTTATAAGCTCATCGGAGCA‐3′ | 5′‐CATTTCTGGGTGGTTCCTTT‐3′ |
HOTAIR (human) | 5′‐CAGTGGGGAACTCTGACTCG‐3′ | 3′‐GTGCCTGGTGCTCTCTTACC‐3′ |
miR‐22 (murine) | 5′‐ACACTCCAGCTGGGTTCGACGGTCAACTTC‐3′ | 5′‐CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTTGAGACAGTTCT‐3′ |
miR‐22 (human) | 5′‐GGTTAAGCTGCCAGTTGAA‐3′ | 5′‐CCAGTGCGTGTCGTGGAGT‐3′ |
2.11. Western blot
Total protein was extracted from mouse kidney tissue and HUVECs using RIPA lysis buffer (Beyotime, cat. no. P0013B) on ice; the obtained lysate was centrifuged at 12,000 × g at 4°C for 30 min. Protein quantification was performed by using a BCA Protein Assay Kit (Thermo Fisher, cat.no. A53225). Proteins were separated by 10% SDS‐PAGE and then transferred to an NC membrane (Pall Bio Trace, cat. no. 66485) using a Bio‐Rad Trans‐Blot Turbo (USA) system. After blocking with 5% fat‐free milk powder in TBST buffer, the membranes were incubated with the following primary antibodies overnight at 4°C: anti‐GAPDH (abcam, cat. no. ab9485), anti‐caspase‐1 (Cell Signaling Technology, cat. no. 3866), anti‐NLRP3 (Cell Signaling Technology, cat. no. 13158), anti‐NLRP1 (Cell Signaling Technology, cat. no. 4990), anti‐GSDMD‐FL (Invitrogen, cat. no. PA5‐104324) and anti‐GSDMD‐N (abcam, cat. no. ab215203). Next, the membranes were incubated with horseradish peroxidase–conjugated anti‐rabbit IgG secondary antibodies for 2 h at room temperature. Bands were detected using a ChemiDoc MP Imaging System (Bio‐Rad), and ImageJ 1.51 software was used for the quantitative analysis of all protein bands.
2.12. Terminal deoxynucleotidyl transferase dUTP nick end labelling (TUNEL) staining
Paraffin sections of mouse kidney tissue were dewaxed in water. TUNEL staining was performed according to the kit instructions. The sections were stained with 3, 3′‐diaminobenzidine (DAB; Servicebio, cat. no. G2111), and the nuclei were stained with haematoxylin. TUNEL‐positive cells, which were stained brown, were counted under 400× magnification. The pyroptosis rate was calculated as the percentage of TUNEL‐positive cells relative to the total number of renal tubular cells. Nuclei stained with haematoxylin were blue, and pyroptosis nuclei stained with DAB were brownish‐yellow.
2.13. Immunofluorescent staining
Frozen sections of mouse kidney tissue were permeabilized in 0.2% Triton X‐100 for 15 min and blocked with 5% bovine serum albumin (BSA; Amresco, cat. no. 0332‐250G) at room temperature for 1 h. Subsequently, the sections were incubated with following antibodies overnight at 4°C: anti‐caspase‐1 (Cell Signaling Technology, Cat. No. 3866), NLRP3 (Cell Signaling Technology, cat. no. 13158) or GSDMD‐FL (Invitrogen, cat. no. Pa5‐104324). Then, the sections were incubated with Cy3‐conjugated secondary anti‐rabbit IgG antibody (Beyotime, cat. no. A0516) at room temperature in the dark for 1 h. The sections were incubated with DAPI (abcam, cat. no. ab104139) for 15 min. The sections were washed with PBS three times after each incubation. Fluorescence was assessed with a laser scanning confocal microscope (Leica).
2.14. Immunohistochemical staining
Renal samples were fixed in 4% paraformaldehyde and embedded in paraffin. The samples were then cut into 5‐µm‐thick sections and incubated with primary antibody, that is anti‐CD68 (abcam, cat. no. ab955), at 4°C overnight, followed by incubation with the appropriate secondary antibody. Then, the sections were stained with diaminobenzidine, and images were captured using a fluorescence microscope (Olympus).
2.15. ELISA
Twenty‐four hours after transfection, the concentrations of IL‐1β (abcam, cat. no. ab100562) and IL‐18 (Novus, cat. no. KA0561) in HUVEC culture supernatants or HUA mouse sera were determined by ELISA. The detection was performed strictly according to the kit instructions.
2.16. Statistical analysis
Statistical analysis was performed using IBM SPSS Statistics 24.0 software (IBM Corporation). The quantitative data are expressed as the mean ± standard deviation (SD). All data were tested for a normal distribution using the Shapiro‐Wilk test. Comparisons between two groups were performed with Student's t test, and multiple comparisons of more than two groups were performed with one‐way analysis of variance (ANOVA). A p value less than 0.05 was considered to be statistically significant.
3. RESULTS
3.1. High UA levels promote an increase in HOTAIR expression and induce inflammation
Serum from patients with hyperuricaemia and healthy individuals was collected for qPCR analysis. Compared with that in serum from healthy individuals, the expression of HOTAIR in serum from hyperuricaemia patients was significantly higher (Figure 1A). Serum levels of inflammatory cytokines were determined by ELISA. The results showed that compared to those in the healthy control group, the serum inflammatory cytokine levels of IL‐1β and IL‐18 in hyperuricaemia patients were significantly higher (Figure 1B). Similarly, in the hyperuricaemia mouse model, the expression of HOTAIR, as determined by qPCR, in the kidney tissue of model mice was significantly higher than that in tissue from the healthy control group (Figure 1C), and the serum inflammatory cytokines IL‐1β and IL‐18 were also significantly higher in the model mice than in the control group (Figure 1D). Furthermore, immunohistochemical staining of the macrophage marker CD68 in renal tissue sections showed that CD68+ macrophage infiltration increased around blood vessels in the glomerular mesangial area and renal interstitium in hyperuricaemia mice; statistical analysis indicated that the difference between the groups was significant (Figure 1E).
Subsequently, HUVECs were cultured and stimulated with 600 μmol/L UA for 24 h. qPCR showed that the expression of HOTAIR in cells stimulated with HUA group was significantly higher than that in cells of the control group (Figure 1F); furthermore, the levels of the inflammatory cytokines IL‐1β and IL‐18 in the culture supernatant was also significantly higher in the HUA group (Figure 1G).
3.2. HUA levels induce NLRP3 inflammasome activation and pyroptosis in endothelial cells
To determine whether high UA levels activate the NLRP3 inflammasome in endothelial cells and to assess the effect on pyroptosis, HUVECs were stimulated with 600 μmol/L UA for 24 h. Western blot results showed that compared with that in the control group, the expression of NLRP3 increased and the expression of pyroptosis‐related proteins, including caspase‐1, GSDMD‐FL and GSDMD‐N, significantly increased in the HUA treatment group (Figure 2A). The CCK‐8 method was used to examine the effect of HUA on the proliferation of HUVECs. The results showed that compared with that of cells in the control group, the growth of the cells in the experimental group was significantly inhibited (Figure 2B). Furthermore, LDH in the culture supernatant was analysed using an LDH assay kit; LDH release in the experimental group was also significantly higher (Figure 2C).
Furthermore, we examined the status of inflammasome activation and pyroptosis in kidney tissue from hyperuricaemia mice. The results showed that the protein expression levels of NLRP3, caspase‐1, GSDMD‐FL and GSDMD‐N in kidney tissue from hyperuricaemia mice were significantly higher than those in kidney tissue from mice in the saline control group (Figure 2D). Tissue immunofluorescence results indicated that the expression of NLRP3, caspase‐1 and GSDMD‐FL was distributed throughout the glomeruli of the hyperuricaemia group; the glomerular fluorescence intensity in the hyperuricaemia group was significantly higher than that in the control group (Figure 2E–G). Similarly, compared with that in the control group, serum LDH in hyperuricaemia mice was significantly higher (Figure 2H), and the number of kidney TUNEL‐positive cells was significantly higher (Figure 2I). Both in vitro and in vivo experimental results indicated that HUA induced NLRP3 inflammasome activation and pyroptosis in the cells.
3.3. miR‐22 binds to HOTAIR and NLRP3
To explore the regulatory relationship between HOTAIR and NLRP3, we used bioinformatics prediction and analysis (www.mircode.org), and the results suggest that HOTAIR might be a competing endogenous RNA (ceRNA) of miR‐22. HOTAIR and miR‐22 have potential binding sites (Figure 3A). qPCR detection showed that miR‐22 expression in serum from HUA patients was significantly down‐regulated; there was a strong negative correlation between miR‐22 and HOTAIR expression (r 2 = −0.77) (Figure 3B,C). Similarly, miR‐22 expression was significantly down‐regulated in serum from HUA mice (Figure 3D). miR‐22 down‐regulation was also observed in endothelial cells cultured in UA (Figure 3E). Furthermore, the mutated sequence of full‐length HOTAIR or the seed region was cloned into the psiCHECK2 vector and co‐transfected into HEK‐293T cells with a miR‐22 mimic or a miR‐22 inhibitor. The luciferase assay results showed that the miR‐22 mimic significantly inhibited the luciferase activity of psiCHECK‐WT‐HOTAIR; however, the mimic did not significantly inhibit the luciferase activity of mutant MT‐HOTAIR (Figure 3F).
TargetScan (www.targetscan.org) online software analysis suggested that there was a miR‐22 binding region in the 3‐UTR of NLRP3, suggesting that NLRP3 may be the target gene of miR‐22 and NLRP3 and miR‐22 have potential binding sites (Figure 3A). Subsequently, a luciferase reporter assay confirmed that the miR‐22 mimic significantly inhibited luciferase activity in wild‐type psiCHECK‐WT‐NLRP3 but had no significant inhibitory effect on the luciferase activity of psiCHECK‐MT‐NLRP3 (Figure 3G).
miRNAs form an RNA‐induced silencing complex (RISC) with RNA via Ago2 and then induce gene silencing.32 Based on the above results, we speculated that HOTAIR might bind with miR‐22 and Ago2 to form a RISC, which was further verified by the RIP experiment. The results showed that the amounts of HOTAIR and miR‐22 that immunoprecipitated with Ago2 were significantly higher than those that precipitated with the IgG control (Figure 3H).
Finally, we applied a biotin‐labelled pulldown assay to further explore whether miR‐22 and HOTAIR could direct binding. Consistent with luciferase results, miR‐22 was precipitated by wild‐type HOTAIR but not HOTAIR mutant (Figure 3I).
3.4. HOTAIR acts as a molecular sponge to adsorb miR‐22 and cause endothelial cell inflammation and pyroptosis
We constructed and obtained a HOTAIR overexpression lentivirus, which was used to infect HUVECs that were stimulated and cultured in UA. The qPCR results showed that compared with the no‐load vector group, the HOTAIR‐transfected group showed significantly upregulated HOTAIR expression and significantly down‐regulated miR‐22 (Figure 4A). Western blot results showed that after HOTAIR overexpression in endothelial cells, the expression levels of the NLRP3 inflammasome, caspase‐1 and the pyroptosis‐related proteins GSDMD‐N and GSDMD‐FL were all upregulated (Figure 4B). In addition, the levels of the inflammatory cytokines IL‐1β and IL‐18 in the supernatant of cells overexpressing HOTAIR significantly increased. The release of LDH also significantly increased. Cell proliferation was significantly lower in the HOTAIR‐transfected group than in the no‐load vector group (Figure 4C–E).
However, after using a lentivirus to overexpress shRNA and knock down HOTAIR in HUVECs stimulated with HUA, the opposite effects were observed. Compared with the unrelated shRNA vector group (scramble), in the knockdown group, the expression of HOTAIR was down‐regulated and miR‐22 was significantly upregulated in HUVECS (Figure 4F). The expression levels of the NLRP3 inflammasome, caspase‐1 and pyroptosis‐related proteins GSDMD‐N and GSDMD‐FL were all down‐regulated (Figure 4G), the release of the inflammatory cytokines IL‐1β, IL‐18 and LDH was reduced (Figure 4H,I), and cell proliferation significantly increased (Figure 4J).
On this basis, cells overexpressing HOTAIR were co‐transfected with a miR‐22 mimic. Compared to that in the microRNA scramble control group, the expression levels of the NLRP3 inflammasome, caspase‐1, and pyroptosis‐related proteins GSDMD‐N and GSDMD‐FL in the cells co‐transfected with the mimic all decreased (Figure 4K); in addition, the release of the inflammatory cytokines IL‐1β and IL‐18 and LDH in the culture supernatant significantly decreased (Figure 4L,M), and cell proliferation significantly increased (Figure 4N).
3.5. High UA promoted endothelial cell inflammation and pyroptosis via HOTAIR/miR‐22
To confirm whether HUA promoted endothelial cell inflammation and pyroptosis via HOTAIR/miR‐22, we added miR‐22 mimic and AMO‐22 to UA‐treated HUVECs after HOTAIR knockdown by lentivirus, respectively. The expression levels of the pyroptosis‐related proteins NLRP3, caspase‐1, GSDMD‐N and GSDMD‐FL in the down‐regulation of HOTAIR or miR‐22 mimic group were significantly lower than those in the high UA‐only group (Figure 5A). The release of the inflammatory cytokines IL‐1β and IL‐18 and LDH into the culture supernatant was also significantly lower in the down‐regulation of HOTAIR or miR‐22 mimic group than those in the high UA‐only group (Figure 5B,C), and cell proliferation significantly increased in the down‐regulation of HOTAIR or miR‐22 mimic group than those in the high UA‐only group (Figure 5D). However, the levels of these proteins were significantly higher in the suppression of miR‐22 and HOTAIR knockdown group than in the HOTAIR knockdown group (Figure 5A). The release of inflammatory cytokines IL‐1 and IL‐18 and LDH was also significantly higher in the suppression of miR‐22 and HOTAIR knockdown group than in the HOTAIR knockdown group (Figure 5E,F). Cell proliferation was significantly lower in the suppression of miR‐22 and HOTAIR knockdown group than in the HOTAIR knockdown group (Figure 5G).
3.6. HUA cause endothelial cell inflammation and pyroptosis by regulating the miR‐22/NLRP3 axis through HOTAIR
To further investigate whether HOTAIR induces inflammation and pyroptosis through the NLRP3 inflammasome, we used shRNA‐expressing lentiviruses to knock down NLRP3 expression in HOTAIR‐overexpressing endothelial cells, followed by HUA stimulation and culture. The results showed that after NLRP3 knockdown, the overexpression of HOTAIR did not induce the upregulation of pyroptosis‐associated proteins caspase‐1, GSDMD‐N and GSDMD‐FL, and the expression levels of these proteins were significantly lower than those in the HUA‐only treatment group (Figure 6A). Additionally, there were no significant differences in the release of the inflammatory cytokines IL‐1β and IL‐18 and LDH into the culture supernatant, but lower than those in the HUA‐only treatment group (Figure 6B,C), and there were no abnormal changes in cell proliferation (Figure 6D). Furthermore, we conducted an experiment to verify that whether upregulating NLRP3 expression could rescue the effect of silencing of HOTAIR on cell pyroptosis. We used shRNA‐expressing lentiviruses to knock down HOTAIR expression in NLRP3‐overexpressing endothelial cells, followed by UA stimulation and culture. The results showed that after HOTAIR knockdown, the overexpression of NLRP3 induced the upregulation of pyroptosis‐associated proteins, including NLRP3, caspase‐1, GSDMD‐N and GSDMD‐FL, and the expression levels of these proteins were significantly higher than those in the HOTAIR knockdown group (Figure 6E). Additionally. The secretion of the inflammatory cytokines IL‐1β and IL‐18 and LDH significantly increased (Figure 6F,G) in NLRP3‐overexpressing group, and cell proliferation also significantly inhibited in NLRP3‐overexpressing group (Figure 6H).
Next, we used AMO‐22 (miR‐22 inhibitor) to knock down miR‐22 in cells, which were then stimulated with HUA. The qPCR results showed that HOTAIR expression did not change significantly (Figure 7A). Compared with that in the HUA‐only group, the expression of the NLRP3 inflammasome, caspase‐1 and the pyroptosis‐related proteins GSDMD‐N and GSDMD‐FL increased (Figure 7B) and the secretion of the inflammatory cytokines IL‐1β and IL‐18 and LDH significantly increased (Figure 7C,D) in the AMO‐22‐treated cells.
In further experiments, the cells were stimulated with high levels of UA after transfection with a miR‐22 mimic. Compared with those in the control group, the expression levels of the NLRP3 inflammasome, caspase‐1 and the pyroptosis‐related proteins GSDMD‐N and GSDMD‐FL in the mimic group did not change significantly; however, the expression levels of those proteins were significantly lower in the mimic group than in the HUA‐only group (Figure 7E). The release of the inflammatory cytokines IL‐1β and IL‐18 and LDH into the culture supernatant was also significantly lower in the mimic group than in the high UA‐only group (Figure 7F,G).
Interestingly, the above phenomena were not observed when the miR‐22 mimic was added to the NLRP3 overexpression group. Expression levels of the pyroptosis‐related proteins NLRP3, caspase‐1, GSDMD‐N and GSDMD‐FL were detected by Western blot, and the levels of these proteins were significantly higher in the NLRP3 overexpression group than in the no‐load vector group (Figure 7H). The release of inflammatory cytokines IL‐1 and IL‐18 and LDH was also significantly higher in the NLRP3 overexpression group than in the no‐load vector group (Figure 7I,J).
3.7. Inhibition of HOTAIR attenuates inflammatory kidney injury in hyperuricaemia mice
To explore novel strategies for the targeted treatment of UA nephropathy, based on the above studies, we injected shHOTAIR lentiviruses, via tail vein, into hyperuricaemia mice and subsequently assessed the inflammation status in kidney tissues The results showed that the protein expression levels of NLRP3 and caspase‐1 in the renal tissues of the treatment group were significantly lower than those in the unrelated lentivirus (scramble) group (Figure 8A). The immunofluorescence intensity of NLRP3 and caspase‐1 in kidney tissue from the treatment group was significantly lower than that in kidney tissue from the model group (Figure 8B,C). Furthermore, in the treatment group, serum inflammatory cytokines IL‐1β and IL‐18 decreased, with a statistically significant difference compared with the control group (Figure 8D). Further immunohistochemical analysis of kidney sections revealed that compared with the model‐only group, the use of shHOTAIR lentivirus to down‐regulate HOTAIR significantly reduced the infiltration of CD68+ macrophages around the blood vessels of the glomerular mesangial area and renal interstitium (Figure 8E).
4. DISCUSSION
Studies have confirmed that HOTAIR plays a role in diabetic retinopathy and leads to diabetic retinal endothelial cell dysfunction.33 Related studies have also shown that HOTAIR is highly expressed in patients with diabetic nephropathy and in the kidney tissues of animals.34 However, the role and mechanism of HOTAIR in HUA‐induced endothelial injury are not fully understood. In this study, we found that the expression level of HOTAIR in hyperuricaemia patients was significantly higher than that in the normal population. The same results were also observed in a hyperuricaemia mouse model and in HUVECs stimulated with HUA. lncRNAs can function as endogenous competitive RNAs of miRNAs to regulate miRNA expression and biological gene functions by sequence complementarity.35, 36 Therefore, we hypothesized that HOTAIR plays a similar role in HUA. Then, what is its target miRNA? Using bioinformatics prediction tools, we determined that miR‐22 has a HOTAIR binding site; a dual‐luciferase reporter assay confirmed that miR‐22 can bind to HOTAIR, a result that is consistent with literature reports.31 miR‐22 is closely associated with a variety of diseases, including tumours and cardiovascular diseases.37, 38 In sepsis‐induced acute kidney injury, HOTAIR can act as a molecular sponge to adsorb miR‐22, causing renal tubular epithelial cell apoptosis.31 However, there is currently no evidence supporting the role of miR‐22 in HUA‐induced kidney injury. We observed a decrease in serum miR‐22 expression in hyperuricaemia patients and a negative correlation between miR‐22 and HOTAIR expression. In in vitro experiments, HOTAIR overexpression in endothelial cells significantly reduced miR‐22 expression and increased the secretion of inflammatory cytokines; these effects were offset by a miR‐22 mimic. In contrast, after HOTAIR knockdown and HUA stimulation, the expression levels of miR‐22 and inflammatory cytokines were not significantly different from those in the normal control group. RNA pulldown assay result showed that HOTAIR could also pull down miR‐22 by using a biotin‐labelled specific HOTAIR probe through a pulldown system, indicating a sequence‐specific recognition between miR‐22 and HOTAIR.RIP experiments suggested that Ago2 immunoprecipitated with a higher amount of HOTAIR and miR‐22 than did IgG. Therefore, the competitive binding between HOTAIR and miR‐22 transcripts is based on forming a RISC with Ago2, and HOTAIR might promote HUA‐induced inflammatory kidney injury by competitively binding miR‐22.
Actually, lncRNAs can regulate gene expression at a variety of levels.39 In addition to acting as molecular sponge to bind miRNAs and prevent miRNAs from binding to their target mRNAs,36 lncRNAs can also regulate gene expression as epigenetic regulators. lncRNAs could also regulate gene expression through epigenetic modification. LncRNAs can interact with chromatin and then recruit protein complexes to remodel chromatin states and change DNA/RNA methylation status, thus regulating gene expression.40 NEAT1, a cancer lncRNA, controls 13.3% of genes in the PI3K‐AKT signalling pathway by interacting with distal regulatory elements.41 H19 binds EZH2 in glioblastoma cells, and that EZH2 binding to NKD1 and other promoters is impaired by H19 silencing.42 Therefore, it is worth further exploring whether epigenetic regulation plays a role in HOTAIR‐induced endothelial injury in HUA.
Numerous studies have confirmed that inflammatory responses are closely associated with the occurrence and development of hyperuricaemia.4, 7, 8 As a newly discovered mode of programmed cell death, pyroptosis promotes the release of inflammatory cytokines and accelerates disease progression. Studies have shown that pyroptosis is closely related to the occurrence and development of UA nephropathy.43 The canonical pyroptosis pathway relies on caspase‐1 activation.44 Through the sensing of pathogen‐related molecular patterns and/or damage‐associated molecular patterns, including influenza viruses, listeria monocytogenes, extracellular ATP, hyaluronic acid, glucose, amyloid‐β, silicon, uric acid crystals and cholesterol crystals, intracellular pattern recognition receptors activate the NLRP3 inflammasome to activate caspase‐1. Activated caspase‐1, on the one hand, cleaves the gasdermin D protein to form a peptide segment containing the active N‐terminal domain of gasdermin D, which induces cell membrane perforation, cell rupture and content release and causes pyroptosis.45, 46 On the other hand, activated caspase‐1 cleaves IL‐1β and IL‐18 precursors to form active IL‐1β and IL‐18, which are released extracellularly to recruit inflammatory cells that aggregate during the inflammatory response.45 High level of UA in the blood leads to the formation of urate crystal, which would deposit in the renal interstitium and lead to inflammation. UA, as a damage‐associated molecular pattern, can activate the NLRP3 inflammasome in macrophages, which in turn leads to pyrotosis.47 We found that in HUA‐treated HUVECs, the NLRP3 inflammasome was activated, followed by pyroptosis and an inflammatory response. An increase in CD68+ cell infiltration was also observed in hyperuricaemia mice, suggesting inflammatory injury in the renal microcirculation and endothelium in this model and the release of inflammatory factors, the infiltration of chemotactic inflammatory cells and the aggravation of kidney damage. Notably, in the present study, gain‐ or loss‐of‐function experiments indicated that NLRP3 overexpression induced an inflammatory response and pyroptosis in HUVECs, whereas the pre‐treatment of HUVECs with shNLRP3 to knock down NLRP3 gene expression followed by UA stimulation had opposite effects. These results suggest that the NLRP3 inflammasome plays an important role in the pathogenesis of HUA‐induced renal injury.
How does HOTAIR, which is highly expressed in endothelial cells in a HUA environment, mediate NLRP3 activation and pyroptosis? Bioinformatic analysis indicated that miR‐22, which binds to HOTAIR, can also bind to the 3′‐UTR region of NLRP3. A dual‐luciferase reporter assay also confirmed this result. Subsequent in vivo and in vitro experiments further demonstrated that high levels of HOTAIR expression and decreased miR‐22 expression occurred in a HUA environment, whereas the expression levels of pyroptosis‐related proteins (caspase‐1, NLRP3, GSDMD‐N and GSDMD‐FL) were elevated, LDH release was elevated, and cell proliferation was significantly inhibited, demonstrating the occurrence of pyroptosis. If HOTAIR expression in endothelial cells was knocked down or a miR‐22 mimic was used, the opposite effect was achieved. These results suggested that HOTAIR regulates the expression of NLRP3 by competitively binding to miR‐22, thereby inducing inflammation and pyroptosis. This regulatory mechanism of lncRNAs on pyroptosis is supported by the results of some studies. HOTAIR activates NLRP3‐mediated pyroptosis in SH‐SY5Y cells by negatively regulating miR‐326, thereby promoting neuronal injury in Parkinson's disease.48 In calcium oxalate–induced kidney stones, lncRNA‐00339 promotes renal tubular epithelial cell pyroptosis by regulating the miR‐22‐3p/NLRP3 axis.49
We examined the inhibitory effect on endothelial cell inflammation and pyroptosis in HUVEC through down‐regulation of HOTAIR. Compared to UA‐only group, we observed that the expression levels of pyroptosis‐related proteins were decreased, inflammatory cytokines and LDH release was decreased, and cell proliferation was significantly increased. We observed the same result when miR‐22 was overexpressed. What is more, suppression of miR‐22 restrained the inhibitory effects of HOTAIR knockdown on the inflammatory response and pyroptosis. We also observed that after the inhibition of miR‐22 by AMO‐22 in a HUA environment, the release of pyroptosis‐related proteins, inflammatory cytokines and LDH further increased compared to that in the HUA‐alone group; notably, the expression of HOTAIR was not affected by AMO‐22. The results further suggest that miR‐22 is a downstream target of HOTAIR. In addition, a miR‐22 mimic significantly reduced the expression of NLRP3 and other pyroptosis‐related proteins (caspase‐1, GSDMD‐N and GSDMD‐FL) in a HUA environment; furthermore, the release of inflammatory cytokines and LDH was also significantly reduced. However, the miR‐22 mimic could not reverse the inflammatory response and pyroptosis caused by NLRP3 overexpression, indicating that NLRP3 is a downstream target of miR‐22. Therefore, we infer that lncRNA‐HOTAIR induces pyroptosis of endothelial cells in a HUA environment through the miR‐22/NLRP3 axis and induces inflammatory injury.
Currently, the treatments for HUA are primarily drugs that inhibit UA production and promote UA excretion, while simultaneously improving quality of life.50, 51 Although some studies have developed inhibitors that target inflammasomes,52, 53 there is no report showing effective treatment for HUA‐induced inflammatory renal injury. Through tail vein injection of a shHOTAIR lentivirus, we attempted targeted gene therapy for hyperuricaemia mice. We found that shHOTAIR significantly improved the hyperuricaemia induced inflammatory state of the kidney, providing a preliminarily basis for the feasibility of gene‐targeted therapy for UA nephropathy.
A recent study deserves our attention. Battistelli et al focused on a strategy to counteract HOTAIR activity which is worth further exploring.54 In their study, they validated for the first time a dominant negative‐based RNA strategy to interfere with a pivotal function of a lncRNA. They designed a HOTAIR deletion mutant form (called HOTAIR‐sbid) to correspond to the putative Snail‐binding and depleted of the EZH2‐binding domain. HOTAIR‐sbid acted as a dominant negative of the endogenous HOTAIR. In both murine and human tumour cells, HOTAIR‐sbid impaired the ability of HOTAIR to bind Snail and, in turn, trigger H3K27me3/EZH2‐mediated repression of Snail epithelial target genes. HOTAIR‐sbid was proven to reduce cellular motility, invasiveness, anchorage‐independent growth and not impair the TGF‐ mediated mesenchymal gene expression. They provide evidence on a lncRNA‐based strategy to treat diseases caused by abnormal expression of LncRNAs. We will apply this strategy in our research in the future.
In summary, this study elucidated the mechanism underlying the promotion of inflammatory renal injury by HOTAIR in a HUA environment. As a ceRNA of miR‐22, HOTAIR promotes the expression of the NLRP3 inflammasome in endothelial cells and induces inflammation and pyroptosis. Therefore, HOTAIR is proposed as a suitable therapeutic target for UA nephropathy, providing a novel theoretical basis for developing new drugs and correcting endothelial dysfunction in a HUA environment.
CONFLICT OF INTEREST
The authors declare that they have no conflict of interest.
AUTHOR CONTRIBUTION
Kun Chi: Writing‐original draft (equal). Xiaodong Geng: Writing‐original draft (equal). Chao Liu: Data curation (equal). Yang Zhang: Formal analysis (equal). Jie Cui: Formal analysis (equal). GuangYan Cai: Data curation (equal). Xiangmei Chen: Formal analysis (equal). Fangfang Wang: Formal analysis (equal). Quan Hong: Writing‐original draft (equal).
ACKNOWLEDGEMENT
We would like to acknowledge the reviewers for their helpful comments on this paper.
Chi K, Geng X, Liu C, et al. LncRNA‐HOTAIR promotes endothelial cell pyroptosis by regulating the miR‐22/NLRP3 axis in hyperuricaemia. J Cell Mol Med. 2021;25:8504–8521. 10.1111/jcmm.16812
Kun Chi and Xiaodong Geng contributed equally to this work.
Funding information
Project supported by: Fostering Fund of Chinese PLA General Hospital for National Distinguished Young Scholar Science Fund (2019‐JQPY‐002), National Natural Science Foundation of China (81870491, 82070741, 81670694), National Key Research and Development Project (2018YFE0126600), the Science and Technology Project of Beijing China (Z191100006619001).
Contributor Information
Fangfang Wang, Email: doctorfancy@126.com, Email: redhq@163.com.
Quan Hong, Email: doctorfancy@126.com, Email: redhq@163.com.
DATA AVAILABILITY STATEMENT
The data that support the findings of this study are available from the corresponding author upon reasonable request.
REFERENCES
- 1.Nakagawa T, Cirillo P, Sato W, et al. The conundrum of hyperuricemia, metabolic syndrome, and renal disease. Intern Emerg Med. 2008;3(4):313‐318. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Kang DH, Nakagawa T. Uric acid and chronic renal disease: possible implication of hyperuricemia on progression of renal disease. Semin Nephrol. 2005;25(1):43‐49. [DOI] [PubMed] [Google Scholar]
- 3.Wang H, Zhang H, Sun L, Guo W. Roles of hyperuricemia in metabolic syndrome and cardiac‐kidney‐vascular system diseases. Am J Transl Res. 2018;10(9):2749‐2763. [PMC free article] [PubMed] [Google Scholar]
- 4.Isaka Y, Takabatake Y, Takahashi A, Saitoh T, Yoshimori T. Hyperuricemia‐induced inflammasome and kidney diseases. Nephrol Dial Transplant. 2016;31(6):890‐896. [DOI] [PubMed] [Google Scholar]
- 5.Yu S, Hong Q, Wang Y, et al. High concentrations of uric acid inhibit angiogenesis via regulation of the Kruppel‐like factor 2‐vascular endothelial growth factor‐A axis by miR‐92a. Circ J. 2015;79(11):2487‐2498. [DOI] [PubMed] [Google Scholar]
- 6.Hong Q, Wang L, Huang Z, et al. High concentrations of uric acid and angiotensin II act additively to produce endothelial injury. Mediators Inflamm. 2020;2020:8387654. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Bellomo G, Venanzi S, Verdura C, Saronio P, Esposito A, Timio M. Association of uric acid with change in kidney function in healthy normotensive individuals. Am J Kidney Dis. 2010;56(2):264‐272. [DOI] [PubMed] [Google Scholar]
- 8.Kanbay M, Segal M, Afsar B, Kang DH, Rodriguez‐Iturbe B, Johnson RJ. The role of uric acid in the pathogenesis of human cardiovascular disease. Heart. 2013;99(11):759‐766. [DOI] [PubMed] [Google Scholar]
- 9.Jo EK, Kim JK, Shin DM, Sasakawa C. Molecular mechanisms regulating NLRP3 inflammasome activation. Cell Mol Immunol. 2016;13(2):148‐159. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Chi K, Geng X, Liu C, Cai G, Hong Q. Research progress on the role of inflammasomes in kidney disease. Mediators Inflamm. 2020;2020:8032797. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Xiang H, Zhu F, Xu Z, Xiong J. Role of inflammasomes in kidney diseases via both canonical and non‐canonical pathways. Front Cell Dev Biol. 2020;8:106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Schroder K, Tschopp J. The inflammasomes. Cell. 2010;140(6):821‐832. [DOI] [PubMed] [Google Scholar]
- 13.Place DE, Kanneganti TD. Recent advances in inflammasome biology. Curr Opin Immunol. 2018;50:32‐38. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Shi J, Zhao Y, Wang K, et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature. 2015;526(7575):660‐665. [DOI] [PubMed] [Google Scholar]
- 15.Sha W, Mitoma H, Hanabuchi S, et al. Human NLRP3 inflammasome senses multiple types of bacterial RNAs. Proc Natl Acad Sci USA. 2014;111(45):16059‐16064. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Piancone F, Saresella M, Marventano I, et al. Monosodium urate crystals activate the inflammasome in primary progressive multiple sclerosis. Front Immunol. 2018;9:983. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Rashidi M, Simpson DS, Hempel A, et al. The pyroptotic cell death effector Gasdermin D is activated by gout‐associated uric acid crystals but is dispensable for cell death and IL‐1beta release. J Immunol. 2019;203(3):736‐748. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Wang Y, Zhang H, Chen Q, et al. TNF‐alpha/HMGB1 inflammation signalling pathway regulates pyroptosis during liver failure and acute kidney injury. Cell Prolif. 2020;53(6):e12829. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Lin J, Cheng A, Cheng K, et al. New insights into the mechanisms of pyroptosis and implications for diabetic kidney disease. Int J Mol Sci. 2020;21(19):7057. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Priante G, Gianesello L, Ceol M, Del Prete D, Anglani F. Cell death in the kidney. Int J Mol Sci. 2019;20(14):3598. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Tonnus W, Linkermann A. Gasdermin D and pyroptosis in acute kidney injury. Kidney Int. 2019;96(5):1061‐1063. [DOI] [PubMed] [Google Scholar]
- 22.Yang L, Li P, Yang W, et al. Integrative transcriptome analyses of metabolic responses in mice define pivotal LncRNA metabolic regulators. Cell Metab. 2016;24(4):627‐639. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Katsushima K, Natsume A, Ohka F, et al. Targeting the Notch‐regulated non‐coding RNA TUG1 for glioma treatment. Nat Commun. 2016;7:13616. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Bär C, Chatterjee S, Thum T. Long noncoding RNAs in cardiovascular pathology, diagnosis, and therapy. Circulation. 2016;134(19):1484‐1499. [DOI] [PubMed] [Google Scholar]
- 25.Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding RNAs. Cell. 2009;136(4):629‐641. [DOI] [PubMed] [Google Scholar]
- 26.Moran VA, Perera RJ, Khalil AM. Emerging functional and mechanistic paradigms of mammalian long non‐coding RNAs. Nucleic Acids Res. 2012;40(14):6391‐6400. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Yi H, Peng R, Zhang LY, et al. LincRNA‐Gm4419 knockdown ameliorates NF‐kappaB/NLRP3 inflammasome‐mediated inflammation in diabetic nephropathy. Cell Death Dis. 2017;8(2):e2583. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Puthanveetil P, Chen S, Feng B, Gautam A, Chakrabarti S. Long non‐coding RNA MALAT1 regulates hyperglycaemia induced inflammatory process in the endothelial cells. J Cell Mol Med. 2015;19(6):1418‐1425. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Hong Q, Li O, Zheng W, et al. LncRNA HOTAIR regulates HIF‐1alpha/AXL signaling through inhibition of miR‐217 in renal cell carcinoma. Cell Death Dis. 2017;8(5):e2772. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
- 30.Fu WM, Lu YF, Hu BG, et al. Long noncoding RNA Hotair mediated angiogenesis in nasopharyngeal carcinoma by direct and indirect signaling pathways. Oncotarget. 2016;7(4):4712‐4723. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Shen J, Zhang J, Jiang X, Wang H, Pan G. LncRNA HOX transcript antisense RNA accelerated kidney injury induced by urine‐derived sepsis through the miR‐22/high mobility group box 1 pathway. Life Sci. 2018;210:185‐191. [DOI] [PubMed] [Google Scholar]
- 32.Gregory RI, Chendrimada TP, Cooch N, Shiekhattar R. Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Cell. 2005;123(4):631‐640. [DOI] [PubMed] [Google Scholar]
- 33.Zhao D, Zhao Y, Wang J, et al. Long noncoding RNA Hotair facilitates retinal endothelial cell dysfunction in diabetic retinopathy. Clin Sci (Lond). 2020;134(17):2419‐2434. [DOI] [PubMed] [Google Scholar]
- 34.Majumder S, Hadden MJ, Thieme K, et al. Dysregulated expression but redundant function of the long non‐coding RNA HOTAIR in diabetic kidney disease. Diabetologia. 2019;62(11):2129‐2142. [DOI] [PubMed] [Google Scholar]
- 35.Song P, Ye LF, Zhang C, Peng T, Zhou XH. Long non‐coding RNA XIST exerts oncogenic functions in human nasopharyngeal carcinoma by targeting miR‐34a‐5p. Gene. 2016;592(1):8‐14. [DOI] [PubMed] [Google Scholar]
- 36.Kato M, Wang M, Chen Z, et al. An endoplasmic reticulum stress‐regulated lncRNA hosting a microRNA megacluster induces early features of diabetic nephropathy. Nat Commun. 2016;7:12864. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Song SJ, Ito K, Ala U, et al. The oncogenic microRNA miR‐22 targets the TET2 tumor suppressor to promote hematopoietic stem cell self‐renewal and transformation. Cell Stem Cell. 2013;13(1):87‐101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Huang ZP, Wang DZ. miR‐22 in smooth muscle cells: a potential therapy for cardiovascular disease. Circulation. 2018;137(17):1842‐1845. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Schmitz SU, Grote P, Herrmann BG. Mechanisms of long noncoding RNA function in development and disease. Cell Mol Life Sci. 2016;73(13):2491‐2509. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Zhang G, Lan Y, Xie A, et al. Comprehensive analysis of long noncoding RNA (lncRNA)‐chromatin interactions reveals lncRNA functions dependent on binding diverse regulatory elements. J Biol Chem. 2019;294(43):15613‐15622. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Xu H, Li J, Zhou ZG. NEAT1 promotes cell proliferation in multiple myeloma by activating PI3K/AKT pathway. Eur Rev Med Pharmacol Sci. 2018;22(19):6403‐6411. [DOI] [PubMed] [Google Scholar]
- 42.Fazi B, Garbo S, Toschi N, et al. The lncRNA H19 positively affects the tumorigenic properties of glioblastoma cells and contributes to NKD1 repression through the recruitment of EZH2 on its promoter. Oncotarget. 2018;9(21):15512‐15525. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Wang G, Zuo T, Li R. The mechanism of Arhalofenate in alleviating hyperuricemia―Activating PPARγ thereby reducing caspase‐1 activity. Drug Development Research. 2020;81(7):859–866. [DOI] [PubMed] [Google Scholar]
- 44.Xi H, Zhang Y, Xu Y, et al. Caspase‐1 inflammasome activation mediates homocysteine‐induced pyrop‐apoptosis in endothelial cells. Circ Res. 2016;118(10):1525‐1539. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Rathinam VAK, Chan FK. Inflammasome, inflammation, and tissue homeostasis. Trends Mol Med. 2018;24(3):304‐318. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Franchi L, Eigenbrod T, Muñoz‐Planillo R, Nuñez G. The inflammasome: a caspase‐1‐activation platform that regulates immune responses and disease pathogenesis. Nat Immunol. 2009;10(3):241‐247. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Rashidi M, Wicks IP, Vince JE. Inflammasomes and Cell Death: Common Pathways in Microparticle Diseases. Trends in Molecular Medicine. 2020;26(11):1003–1020. [DOI] [PubMed] [Google Scholar]
- 48.Zhang Q, Huang XM, Liao JX, et al. LncRNA HOTAIR Promotes Neuronal Damage Through Facilitating NLRP3 Mediated‐Pyroptosis Activation in Parkinson’s Disease via Regulation of miR‐326/ELAVL1 Axis. Cellular and Molecular Neurobiology. 2020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Song Z, Zhang Y, Gong B, Xu H, Hao Z, Liang C. Long noncoding RNA LINC00339 promotes renal tubular epithelial pyroptosis by regulating the miR‐22‐3p/NLRP3 axis in calcium oxalate‐induced kidney stone. J Cell Biochem. 2019;120(6):10452‐10462. [DOI] [PubMed] [Google Scholar]
- 50.Shekelle PG, Newberry SJ, FitzGerald JD, et al. Management of gout: a systematic review in support of an American College of Physicians Clinical Practice Guideline. Ann Intern Med. 2017;166(1):37‐51. [DOI] [PubMed] [Google Scholar]
- 51.Neogi T. Clinical practice. Gout. N Engl J Med. 2011;364(5):443‐452. [DOI] [PubMed] [Google Scholar]
- 52.Coll RC, Robertson AA, Chae JJ, et al. A small‐molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat Med. 2015;21(3):248‐255. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Ludwig‐Portugall I, Bartok E, Dhana E, et al. An NLRP3‐specific inflammasome inhibitor attenuates crystal‐induced kidney fibrosis in mice. Kidney International. 2016;90(3):525–539. [DOI] [PubMed] [Google Scholar]
- 54.Battistelli C, Garbo S, Riccioni V, et al. Design and functional validation of a mutant variant of the LncRNA HOTAIR to counteract snail function in epithelial‐to‐mesenchymal transition. Cancer Res. 2021;81(1):103‐113. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
The data that support the findings of this study are available from the corresponding author upon reasonable request.